Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026

Regulatory News: Sensorion (FR001401A9Z0 ALSEN) ("the Company"), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent ...